DAB2 and ovarian cancer: In another independent dataset (GSE2109), DAB2 expression was significantly increased in metastatic ovarian cancer tissues compared to primary ovarian cancer tissues for all ovarian cancer subtypes (Fig. 3C, ***p = 0.0009) and for HGSOC tissues (Fig. 3C, ***p = 0.0001).